JXHS2000182 | 阿贝西利片 | abemaciclib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-12-28 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Lilly Del Caribe Inc | Certificate Issued | 2022-01-06 | view |
JXHS2000184 | 阿贝西利片 | abemaciclib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-12-28 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Lilly Del Caribe Inc | Certificate Issued | 2022-01-06 | view |
JXHS2000183 | 阿贝西利片 | abemaciclib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-12-28 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Lilly Del Caribe Inc | Certificate Issued | 2022-01-06 | view |
CYSB2000247 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-10-30 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | Certificate Issued | 2021-08-06 | view |
JXHS2000161 | 注射用盐酸吉西他滨 | gemcitabine hydrochloride | Lyophilized | Chemical Drugs(2.4) | Import Drug Application | 2020-11-09 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Lilly France;Vianex SA | Certificate Issued | 2021-07-26 | view |
JXHS2000160 | 注射用盐酸吉西他滨 | gemcitabine hydrochloride | Lyophilized | Chemical Drugs(2.4) | Import Drug Application | 2020-11-09 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Lilly France;Vianex SA | Certificate Issued | 2021-07-26 | view |
JXHB2000015 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Supplementary Application | 2020-08-25 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-05-09 | view |
JXHB2000014 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Supplementary Application | 2020-08-25 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-05-09 | view |
JXSS2000064 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Import Drug Application | 2020-12-23 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Lilly France;Eli Lilly Nederland BV | In Review | 2021-05-09 | view |
JXHL2100113 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-04-08 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-04-07 | view |
JXHL2100114 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-04-08 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-04-07 | view |
JXHL2100115 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-04-08 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-04-07 | view |
JXSL2100045 | LY3471851注射液 | | Injection | Biological Products(1) | Import Drug Application | 2021-03-31 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-30 | view |
JXHL2100092 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |
JXHL2100091 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |
JXSB2100025 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-19 | view |
JXHL2100090 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |
JXSB2100024 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-19 | view |
JXSB2100023 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-19 | view |
JXHL2100093 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |